On July 31, 2023 G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, reported that it will participate in two August investor conferences (Press release, G1 Therapeutics, JUL 31, 2023, View Source [SID1234633540]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On Monday August 7, 2023, G1’s Chief Executive Officer Jack Bailey and other members of G1’s Executive Team will participate in the 2023 BTIG Virtual Biotechnology Conference. BTIG-hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative.

On Wednesday August 9, 2023, the G1 team will also participate in one-on-one meetings with institutional investors during the 2023 Wedbush PacGrow Healthcare Conference in New York City. If interested in a meeting, please contact your Wedbush PacGrow representative.